Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study

@article{Okin2004RegressionOE,
  title={Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study},
  author={Peter M. Okin and Richard Blyton Devereux and Jennifer S E Liu and Lasse Oikarinen and Sverker Jern and Sverre Erik Kjeldsen and Stevo Julius and Kristian Wachtell and Markku S Nieminen and Bj{\"o}rn Dahl{\"o}f},
  journal={Journal of Human Hypertension},
  year={2004},
  volume={18},
  pages={403-409}
}
The electrocardiogram (ECG) is widely used for detection of left ventricular hypertrophy (LVH). However, whether changes in ECG LVH during antihypertensive therapy predict changes in LV mass remains unclear. Baseline and year-1 ECGs and echocardiograms were assessed in 584 hypertensive patients with ECG LVH by Sokolow–Lyon or Cornell voltage–duration product criteria at entry into the Losartan Intervention For Endpoint reduction in hypertension (LIFE) echocardiographic substudy. A ⩾25% decrease… CONTINUE READING